Notch2 and B cell antigen receptor (BCR) signaling determine whether transitional B cells become marginal zone B (MZB) or follicular B (FoB) cells in the spleen, but it is unknown how these pathways are related. We generated Taok3 −/− mice, lacking the serine/threonine kinase Taok3, and found cell-intrinsic defects in the development of MZB but not FoB cells. Type 1 transitional (T1) B cells required Taok3 to rapidly respond to ligation by the Notch ligand Delta-like 1. BCR ligation by endogenous or exogenous ligands induced the surface expression of the metalloproteinase ADAM10 on T1 B cells in a Taok3-dependent manner. T1 B cells expressing surface ADAM10 were committed to becoming MZB cells in vivo, whereas T1 B cells lacking expression of ADAM10 were not. Thus, during positive selection in the spleen, BCR signaling causes immature T1 B cells to become receptive to Notch ligands via Taok3-mediated surface expression of ADAM10.
B lymphocytes are categorically divided into B1 and B2 cells. B1 cells derive from fetal progenitors and react to a restricted set of microbial ligands in a T cell-independent (TI) manner in serosal cavities and spleen 1 . B2 cells develop continuously in the bone marrow and further mature into FoB cells and MZB cells. FoB cells have a broad repertoire of specificity, recirculate between lymphoid organs and give rise to germinal center B cells that undergo somatic hypermutation in a T cell-dependent manner. MZB cells shuttle between the marginal zone and follicles of the spleen and produce antibodies to encapsulated bacterial and polysaccharide TI antigens. It is still poorly understood how immature transitional B cells are instructed to become a FoB or MZB cell and when exactly this lineage choice is made. It is widely accepted that MZB instruction requires triggering of Notch2 on developing B cells by Delta-like 1 (Dll1) expressed by splenic red pulp sinus endothelial cells or marginal zone reticular cells. Notch2 cleavage by a metalloproteinase and disintegrin-10 (ADAM10) and γ-secretase then releases the intracellular domain of Notch (NICD), which binds to the transcription factor RBP-Jκ in the nucleus and instructs MZB development, together with NF-κB signaling emanating from the BAFF receptor [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] . The quality of BCR signals during positive selection of B cell precursors in the spleen is equally important in B cell fate decisions [14] [15] [16] , and it was proposed that weak or strong BCR signals might render cells receptive or resistant to Notch instruction 17, 18 . Yet how BCR repertoire or signaling controls Notch responsiveness is poorly understood.
The Ste20 family kinases are serine/threonine kinases that participate in a variety of signaling pathways triggered by cellular stress 19, 20 . The Tao kinase subfamily has three members in mammals: TAOK1 (also known as MAP3K16, PSK2 or MARKK); TAOK2 (MAP3K17 or PSK1) and TAOK3 (MAP3K18, JIK or DPK)). Their function is largely unknown. We generated Taok3 −/− mice and found that these mice lacked MZB cells, whereas FoB cells were intact. By unraveling the molecular mechanism of this deficiency, we have discovered how BCR signaling intersects with Notch signaling in immature transitional B cells undergoing positive selection.
RESULTS

Taok3 −/− mice lack MZB cells
In wild-type mice, Taok3 mRNA was expressed predominantly in bone marrow and immune tissues such as spleen, thymus and lymph nodes, but also in lung and gut (Fig. 1a) . To gain insight into the biology of Taok3, we generated Taok3 −/− mice ( Supplementary  Fig. 1a-e) . Overall there was no difference in the cellularity of the various lymphoid organs in mice 6-12 weeks old ( Supplementary  Fig. 1f ). In the spleen, there were no gross differences in the percentage of eosinophils, monocytes, natural killer cells and natural killer T cells between Taok3 −/− and wild-type mice, yet there was a consistent reduction in the number of CD11c + dendritic cells in Taok3 −/− mice (Fig. 1b) . There was a small yet consistent increase in the percentage A r t i c l e s of Ly6G + granulocytes in the spleens of Taok3 −/− mice. The distribution of CD3 + T cells and CD19 + B cells was comparable, yet there was a 25-30% reduction in the number of CD8 + T cells (Fig. 1c) . Among the B cells of the spleen, analysis of cell surface expression of CD21/35 and CD23 discriminates between transitional CD21/35 − CD23 − B cells, which are immature B cells that have just arrived from the bone marrow, CD21/35 int CD23 hi FoB cells and CD21/35 hi CD23 − MZB cells. Transitional B cells express CD93 and can be further divided in CD93 + IgM hi CD23 − T1 and CD93 + IgM hi CD23 hi T2 cells. In Taok3 −/− splenocytes, the percentages of T1, T2 and FoB cells were comparable to that in wild-type, whereas MZB cells were almost completely absent (Fig. 1d-f) .
Histological examination of the spleen revealed that the characteristic rim of IgM + CD1d + MZB cells separated from the IgM lo B cell follicles by the marginal sinus was absent in Taok3 −/− mice (Fig. 1g) . Resident marginal zone metallophilic macrophages (expressing CD169) that line the marginal sinus were present and correctly located in Taok3 −/− mice (Fig. 1h) . MZB cells are specialized for capturing TI type 2 antigens such as Ficoll 21 . Two hours after intravenous injection of FITC-Ficoll, we detected labeled B cells in the vicinity of CD169 + marginal zone metallophilic macrophages in wild-type mice but not Taok3 −/− mice (Fig. 1h) . Collectively, we conclude that Taok3 −/− mice lack MZB cells without compensatory alterations in other B cell subsets. ; n = 4 or 5 mice per experiment) or one experiment (g-i,k; mean + s.e.m. from n = 6 mice per group in i and k, and at least 4 images in g,h). Fig. 2 ). MZB cells acutely produce TI immunoglobulin in response to polysaccharide particulate antigens such as Ficoll 1, 22 . However, in response to immunization with trinitrophenyl (TNP) hapten-conjugated Ficoll, there was no reduction in the concentration of TNP-specific IgG1, IgG3 and IgM in Taok3 −/− compared with wild-type mice ( Fig. 1i and Supplementary Fig. 2 ). The intact TNP-specific immunoglobulin response was not due to compensatory increase in recirculating MZB cells outside the spleen (data not shown). B1 B cells can also respond to TNP-Ficoll antigen, in the complete absence of MZB cells 2 . The numbers of B220 + CD5 + B1a and CD5 − B1b B cells in the peritoneal cavity were identical in wild-type and Taok3 −/− mice (Fig. 1j) , which may explain the intact humoral immune response to TNP-Ficoll. MZB cells are indispensable for mounting low-affinity IgM phosphorylcholine-specific antibody responses to encapsulated bacteria such as Streptococcus pneumoniae when these reach the bloodstream 1,2,23 . We injected 1 × 10 8 heat-inactivated bacteria intravenously and measured the IgM response to antigen 5 d later. Whereas wild-type mice readily mounted an anti-phosphorylcholine IgM response, the titer of phosphorylcholine-specific IgM was severely reduced in Taok3 −/− mice (Fig. 1k) . These findings show that Taok3 −/− mice form normal responses to the TI-2 antigen Ficoll, but not to the TI-1 antigen S. pneumoniae.
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MZB defect of Taok3 −/− mice is B cell-intrinsic
The development and survival of MZB cells depends on integrin signaling and correct positioning in the marginal zone 18, [24] [25] [26] . As the structure of the marginal zone was not normal in Taok3 −/− mice and other defects were found in neutrophils, DCs and CD8 + T cells, we next addressed whether the defect in MZB cell development was cell intrinsic or caused by changes in the stromal structures or other hematopoietic cells. We therefore created mixed bone marrow chimeric mice by lethally irradiating CD45.1.CD45.2 C57BL/6 mice and reconstituting them with an equal mix of CD45.1 wild-type and CD45.2 Taok3 −/− BM cells. Chimerism was complete 6-8 weeks after transfer, with each donor genotype contributing 50% of monocytes and neutrophils in the blood and various organs (data not shown). Whereas CD23 hi CD21/35 lo FoB cells were completely chimeric (Fig. 2a) , CD21 hi CD23 lo MZB cells were generated almost exclusively from the CD45.1 wild-type hematopoietic cells. As the marginal zone was fully restored in chimeric mice (data not shown), these findings demonstrate that the defect in MZB development is not due to changes in environment, but cell-intrinsic. We next evaluated at which stage of B cell development the MZB development might be compromised. In the bone marrow of chimeric mice, pro-B cells, cycling pre-B cells, pre-B cells and immature B cells were all equally distributed among both genotypes (Fig. 2b) . In the spleen however, there was an overrepresentation of T1 cells of the CD45.1 wild-type genotype. This effect was less marked for T2 B cells. Collectively, loss of MZB cells in Taok3 −/− mice is cell intrinsic and B cell development is compromised from the T1 stage onwards.
Gene dosage effect of Taok3 deficiency
To address whether the amount of Taok3 affects B cell development, we analyzed heterozygous Taok3 +/− mice and took advantage of the fact that the gene trap construct made to inactivate the Taok3 locus contained a splice acceptor that was flanked by loxP sites, allowing the partial reversal of the gene trap in cells of interest ( Supplementary  Fig. 1a) . We therefore crossed wild-type, Taok3 +/− and Taok3 −/− mice to mb1-cre mice, which express Cre recombinase under the control of the Cd79a promoter, active from the pre-B cell stage onwards 27 . When we analyzed the composition of splenic B cells in wild-type Cre + , Taok3 −/− Cre − or Taok3 −/− Cre + mice, we found that MZB cells were partially recovered by gene-trap reversal exclusively in the B cell lineage ( Fig. 2c,d (Fig. 3a) . These differences were no longer apparent 18 h later (data not shown), demonstrating that Taok3 was mainly involved in controlling rapid responsiveness to Dll1 ligation.
It is exceedingly difficult to model MZB development in vitro 28, 29 . However, when wild-type CD93 + transitional B cells were cultured (Fig. 3b) . These differences were not due to alterations in BAFF signaling ( Supplementary Fig. 3a ) or BAFF-induced survival (Supplementary Fig. 3b ). Thus, Taok3 was necessary in transitional B cells for rapid Notch signaling and differentiation toward the MZB phenotype.
To address this point more directly, we performed a rescue experiment in which we increased Notch2 expression in Taok3 −/− B cells. It was recently reported that Irf4 −/− mice have an increase in MZB cells explained by a stabilization of intracellular Notch2 (ref. 12). We bred Taok3 −/− and Irf4 −/− mice and confirmed that Irf4 −/− mice had a strong increase in MZB cells compared with Irf4 +/+ mice (Fig. 3c,d) . When Taok3 −/− Irf4 −/− mice were analyzed, the deficiency of MZB cells was completely reversed, and there were even higher percentages of MZB cells compared with wild-type animals. We validated that Taok3 −/− mice did not have an increased intracellular accumulation of IRF4 protein (data not shown). These data show that Taok3 deficiency leads to defective Notch signaling in transitional B cells and that the MZB phenotype of Taok3 −/− mice can be rescued by IRF4 deficiency.
Taok3 controls the surface expression of ADAM10
We next studied how lack of a kinase might lead to reduced Notch signaling. By immunoblot analysis of lysates, Notch2 expression in Taok3 −/− was similar to that in wild-type mice (Supplementary Fig. 4 ). Looking at immunostained splenic sections and flow cytometry, we found that the intensity of CD23 staining on B cell follicles (Fig. 4a) and FoB cells (Fig. 4b) was consistently higher in Taok3 −/− compared with Taok3 +/+ mice. This was not caused by altered Cd23 mRNA (data not shown). We have previously shown that the metalloproteinase ADAM10 determines the amount of CD23 on the B cell plasma membrane by cleaving CD23 to generate a sCD23 fragment 10, 30 . We found that the baseline serum concentration of sCD23 was significantly reduced in Taok3 −/− mice compared with wild-type mice (Fig. 4c) . Injection of the 19G5 antibody against the CD23 stalk causes a conformational change in CD23 rendering it highly sensitive to cleavage by ADAM10 (ref. 10). After 19G5 injection in wild-type mice, there was an almost 100-fold increase in serum levels of sCD23. This effect was strongly reduced in Taok3 −/− mice, suggesting a defect in the enzymatic activity of ADAM10 (Fig. 4d) .
We addressed this defect in ADAM10 bioactivity further by studying the cleavage of other ADAM10 substrates. A well-known substrate of ADAM10 is the amyloid precursor protein (APP), involved in the pathogenesis of Alzheimer's disease 31 . ADAM10 cleaves cell-bound APP into a membrane bound APP α-stub and soluble APPα. As APP is produced by mouse fibroblasts as well as neuronal cells, we generated mouse embryonic fibroblast (MEF) cell lines of wild-type and Taok3 −/− mice. Taok3 −/− MEFs had a consistently lower expression of the APP α-stub on their cell surface, suggesting reduced ADAM10 activity in Taok3 −/− mice. When MEFs were transfected with fulllength APP, MEFs derived from Taok3 −/− mice also generated less soluble APPα in the concentrated supernatant than those from Taok3 +/+ mice, suggestive indeed of reduced ADAM10 bioactivity (Supplementary Fig. 5 ).
ADAM10 is known to cleave substrates when expressed on the cell surface, and we have reported that ADAM10 can be detected by flow cytometry on lymphocytes 10 . We found that 5-6% of CD93 + transitional B cells of the spleen of wild-type mice expressed ADAM10 on their cell surface. This expression was almost completely absent in Taok3 −/− mice (Fig. 4e) . However, the expression of the pool of ADAM10, composed of pro-and of mature ADAM10, in cell lysates of transitional B cells was identical between wild-type and Taok3 −/− mice (Supplementary Fig. 6 ). In Irf4 −/− T1 B cells there was a marked increase in surface ADAM10 staining compared with that in Irf4 +/+ mice. In compound Taok3 −/− Irf4 −/− mice, the deficit in ADAM10 expression seen in Taok3 −/− mice was restored well above the intensity seen in Taok3 wild-type mice, suggesting that lack of IRF4 restored MZB numbers through upregulation of ADAM10 on T1 B cells (Fig. 4f) . There was a strong correlation between the number of T1 cells expressing surface ADAM10 and the final pool of mature MZB cells in mice of various genotype (Fig. 4g) . Collectively, Taok3 −/− mice lacked surface ADAM10 on T1 B cells and the return of ADAM10 on T1 B cells was accompanied by return of MZB cells, suggesting that the expression of ADAM10 on the surface of might be a crucial event in MZB development.
ADAM10 marks MZB commitment in T1 B cells
The lineage choice of transitional B cells to become FoB or MZB cells depends on the repertoire of the BCR and the strength of BCR signaling [14] [15] [16] . We therefore reasoned that positive selection events in MZB cells acting through the BCR in transitional B cells might affect the surface expression of ADAM10. (Fig. 5a) .
We next studied whether positive selection in a more physiological context would also affect ADAM10 surface expression on T1 B cells. Previously, we created transgenic mice expressing the VH81x heavy chain, which pairs with a limited repertoire of endogenous light chains through binding constraints, thus generating a BCR that recognizes an endogenous self-or microbiome-derived ligand. These mice have been used to understand the mechanisms of positive selection of cells in the MZB pool 14 . We crossed Taok3 −/− mice to VH81x transgenic mice and stained spleen sections for the presence of clonotype-specific B cells (Fig. 5b) . In VH81x transgenic mice with wild-type levels of Taok3, the clonotype + cells were almost exclusively found in the splenic marginal zone, whereas in VH81x transgenic Taok3 −/− mice these cells were absent. Flow cytometry also showed massive expansion of MZB cells in VH81x transgenic mice, but when Taok3 was inactivated, MZB cells were absent (Fig. 5c) . We also performed flow cytometry using antibodies recognizing the VH81x immunoglobulin heavy chain and the pairing V κ 1C light chain. This staining revealed that in Taok3 +/+ VH81x transgenic mice most of the clone was found in the CD21 hi MZB cell gate, whereas in Taok3 −/− VH81x transgenic mice there were fewer clonotype-specific B cells among splenic CD19 + cells, and most remaining clonotype-specific cells had a FoB cell phenotype (Fig. 5d,e) . The percentage of T1 cells expressing surface ADAM10 was strongly increased in VH81x transgenic mice, an effect that was abolished by crossing these mice to Taok3 −/− mice (Fig. 5f) . Again, there was a strong correlation between the percentage of mature MZB cells and the percentage of surface ADAM10 + T1 cells in mice across all genotypes (data not shown).
Finally, we reasoned that expression of ADAM10 on T1 B cells might mark commitment of these cells to become MZB cells. The high numbers of T1 B cells in the spleens of VH81x transgenic mice allowed us to obtain enough cells to perform adoptive transfer experiments into B cell-deficient Rag2 −/− mice. We therefore purified CD45.2 + CD93 + transitional B cells by magnetic pre-enrichment and subsequently sorted cells into ADAM10 surface-positive CD23 − T1 B cells, ADAM10 surface-negative CD23 − T1 B cells, and CD23 + T2 B cells (which do not express high levels of ADAM10; see Fig. 4e ). These were injected simultaneously with tenfold greater numbers of CD45.1 wild-type splenic cells, to avoid homeostatic proliferation that might bias toward MZB development (Fig. 5g) . Five days after transfer, we studied the fate of transferred CD45.2 cells by flow cytometry on spleen cells and confocal analysis of the spleen. Whereas T2 B cells and ADAM10 surface-negative T1 B cells gave rise to both FoB and MZB cells, the ADAM10 surface-positive T1 B cells exclusively gave rise to CD21 hi CD23 − MZB cells (Fig. 5h) . Histological analysis of the spleen also revealed that these CD45.2 + ADAM10 + T1-derived MZB cells were predominantly found in the marginal zone of the spleen (Fig. 5h) . Previously, others have proposed that pre-MZB cells can be identified among a pool of TB cells and that these cells exhibit higher expression of CD21 and CD1d, but it is unclear whether this would be at the T1 B or T2 B stage 6, 16 . We found that T1 B cells expressing surface ADAM10 expressed more CD21 and CD1d than T1 B cells lacking ADAM10 surface expression (Supplementary Fig. 7 ). 
A r t i c l e s
These data confirm our hypothesis that ADAM10 surface expression marks progenitor T1 B cells committed to become MZB cells after positive selection.
DISCUSSION
Our understanding of the development of splenic MZB from immature transitional B cells is dominated by three lines of thought 18 . First, integrin and chemokine signals are crucial for retention and complex shuttling of MZB cells in and around the marginal zone. Loss of these interactions leads to loss of MZB cells in many mouse strains 21, 25, 26, 33 . Second, Notch2 ligation by Dll1 expressed on stromal cells is required for MZB development [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] and maintenance of MZB identity 12, 34 . Third, the quality and the strength of the BCR repertoire determine whether positive selection of immature B cells by self ligands or microbiome-derived ligands leads to deletion, FoB cell or MZB development [14] [15] [16] 35 . It has been unclear how these three pathways are related. Pillai et al. proposed that strong BCR signals favor FoB, whereas weak BCR signals promote MZB cell development 17, 18, 36, 37 , although other investigators have disputed this idea 11, 15 . It was proposed that strong BCR signals render transitional cells in the follicle impervious to the presence of Dll1-mediated triggering of Notch2, whereas weak BCR signaling may enhance the expression of one or more components of the Notch2 signaling pathway 36 . These inhibitory or enhancing signals or the precise stage of B cell development where BCR signaling and Notch permissiveness intersect have never been identified. Here, by careful analysis of Taok3 −/− mice, we show that BCR-mediated positive selection of B cell progenitors at the T1 B cell stage is linked to MZB development through acquisition of membrane expression of ADAM10, which cleaves and activates Notch2. ADAM10 is expressed on a subset of transitional B cells, is redistributed to the immunocap following BCR crosslinking and is highly expressed on the surface of T1 B cells. We believe that the 5-10% of ADAM10 + transitional B cells that are found in the steady state represent the cells that are undergoing positive selection to become MZB cells, supported by our observation that these cells become only MZB cells upon adoptive transfer.
How exactly B cell positive selection and BCR signaling intermediates cause Taok3 activation and ADAM10 surface expression will require further study. The levels of Taok3 mRNA remain stable throughout B cell development from hematopoietic cells and are not altered during B cell activation (data not shown), suggesting that Taok3 might be mainly regulated by post-translational modifications or protein stabilization. It was recently proposed that ADAM10 forms a homodimer in the cell membrane, as does ADAM17, a key feature in the proposed regulatory mechanism of ADAM activation 38 . Although we did observe differences in the processing and oligomerization of ADAM10 in Taok3 −/− mice (data not shown), more research is warranted. Much more is known about the regulation of ADAM17, which can also cleave Notch. The phosphorylation of ADAM17 by ERK kinase on Thr735 regulates ADAM17 dimerization and enzymatic activity 39 . A conserved threonine in position 719 might have the same effect on dimerization of ADAM10. Taok3 is a serine/threonine MAP3 kinase and is likely upstream of ERK, JNK or p38 MAP kinase (unpublished data and ref. 40 ). Although it is likely therefore that lack of MAPK-mediated ADAM10 surface expression is the explanation for the MZB phenotype of Taok3-deficient mice, we also must consider additional effects of Taok3 on MAPK-driven activation of NF-κB, as canonical NF-κB1 collaborates with Notch 2 in driving MZB fate determination 8 . We found that the ADAM10-mediated cleavage of APP is also reduced in Taok3 −/− mice, suggesting that the BCR is not the only upstream regulator of Taok3 and ADAM10 bioactivity. However, Taok3 is not absolutely or always required for ADAM10 or Notch2 activation, as Taok3 −/− mice do not phenocopy all aspects of ADAM10 or Notch2 deficiency. Adam10 −/− or Notch2 −/− mutations are embryonic lethal, whereas Taok3 −/− mutations are not. Our in vitro findings using OP9-Dll1 cells to stimulate transitional B cells suggest that the phenotype of Taok3 −/− mice is the result of disruption of short-lived Notch-Notch ligand interactions. Such short-lived interactions might occur on the marginal zone reticular cell network of the B cell follicles and might be restricted in time as a result of the continuous shuttling behavior of MZB cells from the MZ to B cell follicles 5, 24 .
Our data resolve longstanding confusion in the field as to the precise identity of MZB precursors. It was long held that MZB cells emanate from progenitors with a CD23 + T2 B phenotype that express CD1d and CD21 (refs. 6,10,17,41) . Others have also proposed that FoB cells can develop into MZB cells, particularly in immunodeficient and lymphopenic hosts, a process that might be driven by homeostatic proliferation 24, 41, 42 . Data from mice in which the repertoire of developing MZB cells was followed by measuring the junctional diversity of the heavy chain CDR3 region revealed that T1 B cells are the most likely direct progenitors for MZB cells 16 . Our data using adoptive transfer, as well as the strong correlations between ADAM10 expression on T1 B cells and final population size of the MZB pool, suggest that commitment of MZB cells is indeed made at the T1 B cell stage and that surface ADAM10 staining is a robust marker for identifying cells in which MZB commitment is complete. However, we found that some T2 B cells can still differentiate into MZB cells. We predict that those T2 B cells also upregulate ADAM10 surface expression after adoptive transfer in vivo 10 . In conclusion, we have shown that signals from the BCR control MZB lineage choice by regulating the surface expression of the metalloproteinase ADAM10, which has the potential to cleave and activate Notch2 in T1 transitional B cells undergoing positive selection.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. 
ONLINE METHODS
Mice. We generated Taok3 −/− mice from ES cells (clone CC0463 from the Sanger Institute Gene Trap Resource (SIGTR), Cambridge, UK) in which a loxP-flanked splicing acceptor (SA) preceding a nuclear β-galactosidaseneomycin resistance cassette and poly(A) tail was inserted as a gene trap in the intronic region between exon 1 and exon 2 of the Taok3 gene, leading to premature transcriptional termination. ES cells were originally made in the Sv129 background, but germline transmitting mice were backcrossed for ten generations to C57BL/6 mice. Control animals for Taok3 −/− mice were Taok3 +/+ littermates from a heterozygous Taok3 +/− breeding. Irf4 −/− mice were obtained from W. Agace, Lund University, and were originally derived from The Jackson Laboratory. VH81x mice expressing the VH81x heavy chain, which pairs with a limited repertoire of endogenous light chains through binding constraints, have been previously described 14 . mb1-cre mice, in which Cre recombinase expression is under the control of the Cd79a promoter, active from the pre B cell stage onwards, were obtained from The Jackson Laboratory and have been previously described 27 . Mice were maintained under specific pathogenfree conditions. All animal experiments and procedures were approved by the local animal ethics committee of Ghent University.
Flow cytometry. Cells suspensions were obtained from the spleen, lymph nodes or bone marrow of mice 6-8 weeks old through a 100-µm mesh and red blood cell lysis. Surface stainings were performed in PBS at 4 °C using the following antibodies: CD19 (1D3; eBiosciences), CD93 (AA4.1; eBiosciences), CD23 (B3B4; eBiosciences), CD21/35 (4E3; eBiosciences), IgM (Il/41; BD Biosciences), CD1d (1B1; BD Biosciences), CD3 (17A2; eBiosciences), CD4 (RM4-5; eBiosciences), CD8 (53-6.7; eBiosciences), CD11c (N418; eBiosciences), MHCII (M5/114.15.2; eBiosciences), Ly6G (1A8; eBiosciences), Siglec F (E50-2440; BD Biosciences), NK1.1 (PK136; BD Biosciences) and ADAM10 (139712; R&D Systems). For live versus dead cell discrimination, we used the fixable viability dye eFluor506 (eBiosciences). A single-step labeling protocol was used, followed by washing in PBS.
For analysis of various B cell progenitors in the bone marrow, we stained red blood cell lysed bone marrow cells with antibodies to B220 (RA3-6B2), CD43 (1B11), CD24 (M1/69), CD19 (1D3), lineage (CD3 (17A2), Ly6G (1A8), CD11b (M1/70), Ter119, NK1.1 5PK136)), according to a staining panel obtained from the Immgen consortium. Sample data were acquired with a four-laser BD LSR Fortessa flow cytometer (BD Biosciences) using the BD FACSDiva Software. Data analysis was performed using FlowJo software (Treestar).
Immunizations.
For experiments addressing humoral immune responses, mice (n = 6 per immunization and per genotype) were immunized with TNP-Ficoll (50 µg per animal, i.v. or i.p. in 200 µl PBS) or TNP-KLH in aluminum hydroxide (100 µg per animal, i.p., + 1 mg alum in 200 µl PBS) on day 0, followed by a booster of 100 µg TNP-KLH at day 35. TNP-Ficoll and KLH-TNP were from Biosearch Technologies and aluminum hydroxide was from Sigma. Immune responses were read out at day 0 (baseline), 7 (for TNP-Ficoll), 35 (pre-booster) and 42 for TNP-KLH/alum by measuring serum immunoglobulin levels. TNP-specific IgG1, IgG2, IgG3 and IgM antibodies were measured by commercially available ELISA (Biosearch Technologies).
For measuring the response to Streptococcus pneumoniae, 1 × 10 8 heatinactivated pneumococci (strain D36) were injected intravenously into wild-type (WT) and Taok3 −/− mice and the IgM antibody response to the phosphorylcholine antigen measured 5 d later by ELISA. The IgM response to phosphorylcholine was measured by coating plates with 25 µg/ml of bovine serum albumin-conjugated phosphorylcholine (Biosearch Technologies), followed by detection of serum IgM to phosphorylcholine by anti-IgM antibodies, essentially as described 43 . sCD23 was measured in the serum at day 5 after two injections of 20 µg of 19G5 antibody (directed against the stalk region of CD23) on day 0 and day 2, by commercially available sCD23 ELISA (R&D Systems), as described 10, 30 . This 19G5 antibody causes ADAM10-dependent cleavage of CD23.
Cleavage of amyloid precursor protein.
We generated mouse embryonic fibroblasts (MEFs) from wild-type and Taok3 −/− E13.5 embryos obtained from heterozygous breedings. The liver was removed from the embryos before cell suspensions were made using dispase and trypsin. To immortalize cells, MEFs were transiently transfected with a plasmid containing SV40 large T oncogene cDNA and passaged multiple times to select for transfected cells. In some experiments, subconfluent Taok3 +/+ and Taok3 −/− MEFs were transduced with the recombinant adenovirus Ad5/cytomegalovirus-APP (bearing human APP-695) 44 for 5 h at 37 °C, after which they were kept overnight at 37 °C in Dulbecco′s modified Eagle′s medium supplemented with 10% FBS. Twenty-four hours after infection the medium was changed to minimal-volume Dulbecco′s modified Eagle′s medium supplemented with 0.2% FBS and incubated at 37 °C for 24 h. The conditioned medium was collected and 15 µl was used for the determination of secreted APP fragments (APPs) by SDS-PAGE and immunoblotting with the polyclonal antibody 22C11 (eBioscience). Fifteen microliters was loaded on an SDS-PAGE gel, followed by immunoblotting to visualize specific APPsα with 4B4 antibody (generously provided by Stefan Lichtenthaler, Technische Universität München, Germany) 45 . Cell lysates were made in STE (5 mM Tris pH 7.4; 250 mM sucrose; 1 mM EGTA) + 1% TX-100 and were also analyzed by immunoblot for the detection of APP carboxy-terminal fragments with B63 antibody 45 .
Stimulation of transitional B cells on OP9-Dll1 cells. OP9-Dll1 or control OP9-GFP cells were grown to 80% confluence in 24-well plates in optimized medium (α-MEM supplemented with 20% FCS) as described in detail 46 . For enrichment of transitional B cells, red cell lysis was performed first on spleen suspensions and cells were washed and stained using CD93-APC. Cells were sorted using magnetic bead enrichment with anti-APC beads and LS columns (both from Miltenyi). Subsequently, 5 × 10 5 magnetically enriched CD93 + (4AA.1 + ) transitional B cells were added to the OP9 cells. RNA was extracted 4 and 18 h after setting up the coculture and cDNA was made using a commercially available kit (Transcriptor High Fidelity Kit, Roche). In some experiments, the B cell growth and survival factor BAFF (10 ng/ml; R&D Systems) was added according to a published protocol 29 , and cells were harvested for flow cytometry 3 d later. Survival was analyzed using flow cytometry by adding DAPI to the cells.
Confocal imaging.
Confocal imaging was performed on spleen sections or magnetically enriched transitional B cells. The following antibodies were used: ADAM10 (clone EPR5622, rabbit polyclonal) was purchased from Abcam. IgM (Il/41), B220 (RA3-6B2), CD45.2 (142) and CD1d (1B1) were obtained from BD Biosciences. CD3 (17A2) was obtained from eBiosciences. CD169 (MOMA-1) was obtained from Serotec Bio-Rad. Briefly, 7-µm spleen frozen sections or purified CD93 + transitional cells were fixed for 5 min in PFA 4%. After washing with PBS, sections were stained with the primary antibodies for 60 min at room temperature, followed by a 30-min incubation period with secondary antibodies (all obtained from Jackson Immunoresearch; catalog numbers 712-166-153, 711-166-152, 715-166-150). For visualizing the NP-reactive pool of MZB cells, we injected FITC-labeled Ficoll (Biosearch Technologies) intravenously. After 2 h mice were euthanized and the distribution of FITC-Ficoll on spleen sections, which were also stained for CD169 to delineate the marginal zone, was determined. Sections were counterstained with DAPI. Images were acquired on a Zeiss LSM710 confocal microscope equipped with 488-nm, 561-nm and 633-nm lasers and with a tunable twophoton laser. Images were analyzed with Imaris software.
To reveal the clonotypic B cells of VH81x transgenic mice, we used in-house-generated antibodies to the heavy chain of VH81x (clone MZ21, rat IgG2a, FITC labeled) and the V κ 1C light chain (clone FO27, rat IgG2a, AF647-labeled) 14 .
Immunoblots. Antibodies to Notch2 (D76A6, rabbit) and NF-κB2 p100/p52 (catalog number 4882S) were from Cell Signaling Technologies. Antibodies to Taok3 (clone Ab70297) and ADAM10 (EPR5622) were from Abcam. For immunoblotting, 500 µl cold RIPA lysis buffer supplemented with protease and phosphatase inhibitors (Roche) was added to freshly collected spleens. These were then homogenized using a rod homogenizer and centrifuged at 14,000g at 4 °C for 15 min. Approximately 10 µg of protein was loaded on polyacrylamide gels for immunoblotting.
PCR. mRNA was extracted using the TRIreagent according to manufacturer's specifications (Roche Applied Sciences). cDNA was synthesized with 0.5 mg of
